Crotaline
95%
- Product Code: 111399
Alias:
monocrotaline , monocrotonin
CAS:
315-22-0
| Molecular Weight: | 325.36 g./mol | Molecular Formula: | C₁₆H₂₃NO₆ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00084656 | |
| Melting Point: | 204 °C (dec.)(lit.) | Boiling Point: | |
| Density: | Storage Condition: | 2~8°C |
Product Description:
Crotaline is primarily used in medical research, particularly in the study of its effects on cellular processes. It has been investigated for its potential to induce apoptosis in certain cancer cells, making it a subject of interest in oncology research. Additionally, crotaline is studied for its role in understanding the mechanisms of snake venom toxicity, which aids in the development of antivenom treatments. In pharmacology, it serves as a tool for exploring the interactions between toxins and biological systems, contributing to advancements in drug development and therapeutic strategies.
Product Specification:
| Test | Specification |
|---|---|
| Purity (HPLC) | 95-100 |
| Appearance | White To Off-White Powder |
| Infrared Spectrum | Conforms To Structure |
| Solubility In Chcl3 | Colorless To Light Yellow, Slightly Hazy, 50Mg/Ml |
| Melting Point | 204 Degree Celsius |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | £67.40 |
+
-
|
| 0.250 | 10-20 days | £130.27 |
+
-
|
| 1.000 | 10-20 days | £329.30 |
+
-
|
| 5.000 | 10-20 days | £1,582.74 |
+
-
|
Crotaline
Crotaline is primarily used in medical research, particularly in the study of its effects on cellular processes. It has been investigated for its potential to induce apoptosis in certain cancer cells, making it a subject of interest in oncology research. Additionally, crotaline is studied for its role in understanding the mechanisms of snake venom toxicity, which aids in the development of antivenom treatments. In pharmacology, it serves as a tool for exploring the interactions between toxins and biological systems, contributing to advancements in drug development and therapeutic strategies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :